Cargando…

Exploring the Relationship of Bone Turnover Markers and Bone Mineral Density in Community-Dwelling Postmenopausal Women

AIMS: To explore the relationships of procollagen type 1 N-terminal propeptide (P1NP) and β cross-linked C-telopeptide of type 1 collagen (β-CTX) with bone mineral density (BMD) in postmenopausal women. METHODS: All postmenopausal women were selected from a community-based case-control study. The an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Xu, Zhang, Yili, Xiang, Xinghua, Sun, Menghua, Sun, Kai, Han, Tao, Qi, Baoyu, Xie, Yanming, Zhang, Ranxing, Zhu, Liguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084639/ https://www.ncbi.nlm.nih.gov/pubmed/33968284 http://dx.doi.org/10.1155/2021/6690095

Ejemplares similares

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
por: Sánchez, A., et al.
Publicado: (2016)

Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women Subjected to an Aqua Fitness Training Program
por: Wochna, Krystian, et al.
Publicado: (2019)

Relationship of serum GDF11 levels with bone mineral density and bone turnover markers in postmenopausal Chinese women
por: Chen, Yusi, et al.
Publicado: (2016)

Establishing Reference Intervals for Bone Turnover Markers in the Healthy Shanghai Population and the Relationship with Bone Mineral Density in Postmenopausal Women
por: Hu, Wei-Wei, et al.
Publicado: (2013)

The role of bone turnover markers in screening low bone mineral density and their relationship with fracture risk in the postmenopausal period
por: Mobasseri, Majid, et al.
Publicado: (2023)

Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women
por: Jordan, Natasha, et al.
Publicado: (2006)

Association of Serum Periostin Level with Classical Bone Turnover Markers and Bone Mineral Density in Shanghai Chinese Postmenopausal Women with Osteoporosis
por: Li, Ran, et al.
Publicado: (2021)

Disease Systems Analysis of Bone Mineral Density and Bone Turnover Markers in Response to Alendronate, Placebo, and Washout in Postmenopausal Women
por: Berkhout, J, et al.
Publicado: (2016)

Perirenalfat thickness is associated with bone turnover markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus
por: Wang, Wei, et al.
Publicado: (2022)

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
por: Khanizadeh, Fatemeh, et al.
Publicado: (2018)

Bone turnover markers in serum but not in saliva correlate with bone mineral density
por: Kerschan-Schindl, Katharina, et al.
Publicado: (2020)

Bone Turnover Markers and Bone Mineral Density in Children with Hypophosphatemic Rickets
por: Michałus, Izabela, et al.
Publicado: (2022)

Association of bone mineral density with biochemical markers of bone turnover in hemodialysis children
por: Hajizadeh, Niloofar, et al.
Publicado: (2016)

Associations of long chain polyunsaturated fatty acids with bone mineral density and bone turnover in postmenopausal women
por: Feehan, Orlagh, et al.
Publicado: (2022)

Declining serum bone turnover markers are associated with the short-term positive change of lumbar spine bone mineral density in postmenopausal women
por: Zhao, Shengli, et al.
Publicado: (2022)

The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus
por: Akyay, Ozlem Zeynep, et al.
Publicado: (2023)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle, Ovidiu Alexandru, et al.
Publicado: (2018)

Effect of Traditional Chinese Medicine Product, QiangGuYin, on Bone Mineral Density and Bone Turnover in Chinese Postmenopausal Osteoporosis
por: Shi, Zhen-Yu, et al.
Publicado: (2017)

Evaluation of bone mineral density and bone turnover in children on anticoagulation
por: Thom, Katharina, et al.
Publicado: (2023)

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009)

Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis
por: Wang, Qi-Fei, et al.
Publicado: (2020)

Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men
por: El Hadidy, El Hadidy M, et al.
Publicado: (2011)

Bone and Cartilage Turnover Markers, Bone Mineral Density, and Radiographic Damage in Men with Ankylosing Spondylitis
por: Park, Min-Chan, et al.
Publicado: (2008)

Interrelationships between sarcopenia, bone turnover markers and low bone mineral density in patients on hemodialysis
por: Wang, Yilin, et al.
Publicado: (2023)

Systemic Inflammation Markers Associated with Bone Mineral Density in perimenopausal and Postmenopausal Women
por: Chen, Yijie, et al.
Publicado: (2023)

Association between Bone Mineral Density and Bone Turnover Markers in Breast Cancer Patients and Bone-Only Metastasis
por: Kundaktepe, Berrin Papila, et al.
Publicado: (2021)

IL-6 and Leptin Are Potential Biomarkers for Osteoporotic Fracture Risk Assessment and Prediction of Postmenopausal Women with Low Bone Mass: A Follow-Up Study Using a Regional Sample Cohort
por: Wang, Xu, et al.
Publicado: (2022)

Bone turnover in elderly men: relationships to change in bone mineral density
por: Nguyen, Tuan V, et al.
Publicado: (2007)

Effect of Childbirth Age on Bone Mineral Density in Postmenopausal Women
por: We, Ji Sun, et al.
Publicado: (2018)

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
por: Visvanathan, S, et al.
Publicado: (2008)

Effects of a 'Drug Holiday' on Bone Mineral Density and Bone Turnover Marker During Bisphosphonate Therapy
por: Kong, Sung Yeol, et al.
Publicado: (2013)

Changes in bone mineral density and bone turnover markers in patients undergoing hematopoietic stem cell transplant
por: Pandit, Aditi, et al.
Publicado: (2015)

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
por: Kamimura, M., et al.
Publicado: (2016)

Prevalence of vitamin D inadequacy and bone turnover markers concerning bone mineral density in older persons
por: Jha, Abhinav, et al.
Publicado: (2021)

Effects of metformin on bone mineral density and bone turnover markers: a systematic review and meta-analysis
por: Hu, Jinhua, et al.
Publicado: (2023)

Association Between Bone Mineral Density, Bone Turnover Markers, and Serum Cholesterol Levels in Type 2 Diabetes
por: Yang, Yinqiu, et al.
Publicado: (2018)

GIPR rs10423928 and bone mineral density in postmenopausal women in Shanghai
por: Zhang, Lizhi, et al.
Publicado: (2022)

Associations of IDUA and PTCH1 with Bone Mineral Density, Bone Turnover Markers, and Fractures in Chinese Elderly Patients with Osteoporosis
por: Wang, Qifei, et al.
Publicado: (2019)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
por: Hu, Mingwei, et al.
Publicado: (2023)

Association of follicle‐stimulating hormone with bone turnover markers and bone mineral density in Chinese women across the menopausal transition
por: Li, Lin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pltmgt6ncl027kgi52iq23k7i4